Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA

NCT03054064 is registered in ClinicalTrials.gov with Parker Hannifin Corporation as lead sponsor.

NCT NCT03054064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03054064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
Lead sponsor
Parker Hannifin Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 21, 2017
Completion date
January 17, 2018
Enrollment
48 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident (cva), hemiplegia, stroke